Information  X 
Enter a valid email address

Lipoxen PLC (XEN)

  Print      Mail a friend

Friday 21 January, 2011

Lipoxen PLC

Director/PDMR Shareholding

RNS Number : 8984Z
Lipoxen PLC
21 January 2011




Lipoxen plc

 ("Lipoxen" or the "Company")


Director dealings


The Company was informed on 20 January 2011 that FDS Pharma Ass and Related Parties disposed of 925,000 ordinary shares of 0.5p each ("Ordinary Shares") over 16 separate trades at an average price of 11.23 pence between 16 November and 13 December 2010.


Following these disposals FDS Pharma Ass and Related Parties have an interest in Lipoxen of 41,440,059 Ordinary Shares representing 23.38 per cent of the issued Ordinary Share capital in the Company.




Lipoxen plc

+44 (0)20 7389 5015

M. Scott Maguire, Chief Executive Officer

Singer Capital Markets (nominated adviser)

+44 (0)20 3205 7500

Jeff Keating / Claes Spång

Walbrook PR Ltd

+44 (0)20 7933 8780

Bob Huxford (Media Enquiries)

Mob: 07747 653 908


Paul Cornelius (Investor Enquiries)

Mob: 07866 384 707



This information is provided by RNS
The company news service from the London Stock Exchange